GenMont Biotech Incorporation 3164.TW
3164.TW
GenMont Biotech Incorporation 6850.TWO
BiOptic Inc. 4186.TWO
Taiwan Advance Bio-Pharmaceutical Inc. 6564.TWO
Enimmune corporation 6872.TWO
NaviFUS Corp. 4724.TWO
Meribank Biotech Co., Ltd 1762.TW
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 4195.TWO
Genomics BioSci & Tech. Co.,Ltd. 6846.TWO
Greenyn Biotechnology Co., Ltd 7427.TWO
Great Novel Therapeutics Biotech & Medicals
GenMont Biotech Incorporation 6850.TWO
BiOptic Inc. 4186.TWO
Taiwan Advance Bio-Pharmaceutical Inc. 6564.TWO
Enimmune corporation 6872.TWO
NaviFUS Corp. 4724.TWO
Meribank Biotech Co., Ltd 1762.TW
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 4195.TWO
Genomics BioSci & Tech. Co.,Ltd. 6846.TWO
Greenyn Biotechnology Co., Ltd 7427.TWO
Great Novel Therapeutics Biotech & Medicals
Performance
| Periode | 3164.TW | 6850.TWO | 4186.TWO | 6564.TWO | 6872.TWO | 4724.TWO | 1762.TW | 4195.TWO | 6846.TWO | 7427.TWO |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 2.96 % | 13.98 % | 2.54 % | 25.61 % | -13.99 % | 32.17 % | -1.63 % | 43.06 % | 4.83 % | -15.63 % |
| YTD | -4.98 % | 16.61 % | -9.29 % | -6.24 % | -25.90 % | -32.38 % | -20.03 % | 31.51 % | -8.44 % | -9.48 % |
| 1Y | -14.16 % | 1.31 % | -8.41 % | -27.98 % | -31.10 % | -40.94 % | -35.97 % | 47.23 % | -7.05 % | -20.28 % |
| 3Y | -14.54 % | 50.12 % | -5.98 % | -51.61 % | -4.01 % | -39.03 % | -47.79 % | 38.28 % | 4.53 % | -2.39 % |
| 5Y | -16.96 % | 15.22 % | -46.30 % | -51.12 % | -15.33 % | -39.03 % | -55.49 % | 49.59 % | -11.08 % | -45.35 % |
| 10Y | -36.65 % | 15.22 % | -47.67 % | -27.95 % | -15.33 % | -39.03 % | -18.22 % | 47.92 % | -11.08 % | -45.35 % |
| From the beginning | 22.28 % | 15.22 % | -80.48 % | -27.95 % | -15.33 % | -39.03 % | -56.97 % | -16.20 % | -11.08 % | -45.35 % |